Qube Research & Technologies (QRT)
NRXP icon

Qube Research & Technologies (QRT)’s NRX Pharmaceuticals NRXP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-117
Closed -$285 – 3860
2024
Q2 		$285 Buy
117
+100
+588% +$356 ﹤0.01% 3363
2024
Q1 		$78 Hold
17
– – ﹤0.01% 4194
2023
Q4 		$76 Hold
17
– – ﹤0.01% 4044
2023
Q3 		$43 Buy
+17
New +$57 ﹤0.01% 3826

Other funds holding NRXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OWMIAS
One Wealth Management Investment & Advisory Services Miami Beach, Florida $95.3M AUM 25.31% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NRXP Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of NRX Pharmaceuticals (NRXP) in Q3 2024, closing a stake of 117 shares — an estimated $285 sold.

Qube Research & Technologies (QRT) first reported a position in NRXP in Q3 2023 and held it in 4 quarters. The position peaked at $285 in Q2 2024. 18 funds tracked by Wall St. Rank hold NRXP as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining NRX Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 117 NRX Pharmaceuticals shares in Q3 2024, an estimated $285.
  • Qube Research & Technologies (QRT) first reported a position in NRX Pharmaceuticals in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s NRX Pharmaceuticals position peaked at $285 in Q2 2024.
  • 18 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.